NCT00559286View on ClinicalTrials.gov

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

PHASE4TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Arterial HypertensionDiabetes Mellitus Type 2 IRC or NIR
Interventions
DRUG

Telmisartan

application of 80mg or 20mg Telmisartan per day for 30 days

Trial Locations (1)

52074

University Hospital, Aachen

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

CTCA

UNKNOWN

collaborator

Heidelberg University

OTHER

collaborator

Bayer

INDUSTRY

lead

RWTH Aachen University

OTHER